Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Giuseppe Vaccaro, PhD, is a Research Associate at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) since September 2022. Previously, Giuseppe served as a PhD Student at Medizinische Universität Innsbruck from December 2017 to February 2023 and worked as a Research Assistant at the University of Zurich from 2021 to October 2022. Giuseppe holds a SPIN PhD in Neuroscience from Medizinische Universität Innsbruck, earned between December 2017 and February 2023. Earlier academic achievements include a Laurea Magistrale in Biologia cellulare e molecolare from Alma Mater Studiorum – Università di Bologna (2014-2017) and a Laurea triennale in Biologia/Scienze biologiche, generale from Università degli Studi di Palermo (2010-2014).
This person is not in any offices
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of vision, its diseases and to develop new therapies for vision loss. The institute is constituted as a foundation. IOB started operations in 2018. At IOB, we accelerate the conversion of basic research into innovative treatments which change the field of ophthalmic therapy. Interdisciplinary teams of researchers and clinicians work hand in hand. These problem-solvers and innovators have in-depth knowledge of unmet medical needs, and daily exposure to patients. Together, they improve the understanding of vision, and of the cells involved in eye disease. In this highly collaborative environment, IOB turns discoveries and technologies into clinical benefits for patients with blinding conditions. We help advance the practice of ophthalmic disease based on the genetic, structural and functional understanding of the cell types and their interactions within the human eye. At the Institute of Molecular and Clinical Ophthalmology Basel (IOB), basic researchers and clinicians work hand in hand to advance the understanding of eye diseases and to develop new therapies for vision loss.